A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).
Roche KapoorMatthew P DeekRiley McIntyreNatasha RamanMegan KummerloweIyah ChenMatt GaverHao WangSam DenmeadeTamara LotanChanning PallerMark MarkowskiMichael CarducciMario EisenbergerTomasz M BeerDaniel Y SongTheodore L DeWeeseJason W HearnStephen GrecoCurtiland DeVilleNeil B DesaiElisabeth I HeathStanley LiauwDaniel E SprattArthur Y HungEmmanuel S AntonarakisPhuoc T TranPublished in: BMC cancer (2019)
ClinicaltTrials.gov Identifier: NCT02203695 Date of Registration: 06/16/2014. Date of First Participant Enrollment: 04/16/2015.